Benjamin F. Mcgraw III - 20 Sep 2021 Form 4 Insider Report for AERIE PHARMACEUTICALS INC

Role: Interim Executive Chair, Director
Signature: s/ John LaRocca, Attorney-in-Fact for Benjamin F. McGraw, III
Issuer symbol: N/A
Transactions as of: 20 Sep 2021
Net transactions value: $0
Form type: 4
Filing time: 22 Sep 2021, 17:40:10 UTC
Previous filing: 21 Jun 2021
Next filing: 02 Mar 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AERI	Common Stock	Award	$0	+34,513	+299%	$0.000000	46,063	20 Sep 2021	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	AERI	Stock Option (right to buy)	Award	$0	+102,412		$0.000000	102,412	20 Sep 2021	Common Stock	102,412	$11.59	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Subject to the reporting person's continued service as Interim Executive Chair through the vesting date, these shares of Common Stock are scheduled to vest on the earliest of (i) March 17, 2021 and (ii) the date on which the reporting person's service as Interim Executive Chair ceases following the company's appointment of a new CEO.
F2	Subject to the reporting person's continued service as Interim Executive Chair through the vesting date, this option is scheduled to vest on the earliest of (i) March 17, 2021 and (ii) the date on which the reporting person's service as Interim Executive Chair ceases following the company's appointment of a new CEO.